Development
Tenet Healthcare Corporation
THC
$172.02
-$0.34-0.20%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 611.00M | 469.00M | 499.00M | 414.00M | 411.00M |
| Total Depreciation and Amortization | 870.00M | 867.00M | 852.00M | 855.00M | 841.00M |
| Total Amortization of Deferred Charges | 32.00M | 35.00M | 36.00M | 34.00M | 33.00M |
| Total Other Non-Cash Items | 790.00M | 856.00M | 767.00M | 900.00M | 941.00M |
| Change in Net Operating Assets | 71.00M | -256.00M | -371.00M | -899.00M | -1.14B |
| Cash from Operations | 2.37B | 1.97B | 1.78B | 1.30B | 1.08B |
| Capital Expenditure | -751.00M | -833.00M | -822.00M | -842.00M | -762.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -224.00M | -120.00M | -264.00M | -242.00M | -234.00M |
| Divestitures | 71.00M | 39.00M | 17.00M | 75.00M | 210.00M |
| Other Investing Activities | -65.00M | -28.00M | -6.00M | -25.00M | -22.00M |
| Cash from Investing | -969.00M | -942.00M | -1.08B | -1.03B | -808.00M |
| Total Debt Issued | 1.37B | 1.37B | 1.37B | 2.03B | 2.02B |
| Total Debt Repaid | -1.54B | -1.54B | -1.54B | -2.02B | -2.85B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -200.00M | -340.00M | -340.00M | -300.00M | -250.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -663.00M | -671.00M | -613.00M | -625.00M | -703.00M |
| Cash from Financing | -1.04B | -1.18B | -1.13B | -909.00M | -1.78B |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 370.00M | -154.00M | -417.00M | -639.00M | -1.51B |